IMFL logoIMFL
Invesco International Developed Dynamic Multifactor ETF

2
Loading...
Loading...
News
all
press releases
News Placeholder
TriSalus Life Sciences’ Q4 Loss Exceeds Projections, Revenue Tops Estimates – Retail Stays Pessimistic
The company reaffirmed its previous guidance for 2025 and said it expects sales growth of over 50% and its gross margin to exceed 87%, higher than the 86% reported for 2024.
Stocktwits·6mo ago

Latest IMFL News

View

Advertisement. Remove ads.

Advertisement. Remove ads.